EndoStim Postpones $35 Million IPO
EndoStim, which sells a neurostimulation device used to treat gastroesophageal reflux disease, postponed its IPO on Thursday citing poor market conditions.
The St. Louis, MO-based company was founded in 2009 and booked $1 million in sales for the 12 months ended June 30, 2014. STIM. EndoStim initially filed confidentially on 5/9/2014. Wedbush PacGrow was set to be the sole bookrunner on the deal.
Help employers find you! Check out all the jobs and post your resume.
The St. Louis, MO-based company was founded in 2009 and booked $1 million in sales for the 12 months ended June 30, 2014. STIM. EndoStim initially filed confidentially on 5/9/2014. Wedbush PacGrow was set to be the sole bookrunner on the deal.
Help employers find you! Check out all the jobs and post your resume.